Jagadeesh Ramdas
Expertise in
9
conditions
Expertise in
9
conditions

Overview

Dr. Ramdas is a fellowship-trained specialist in pediatric hematology/oncology and board certified in pediatrics. His clinical interests include general pediatric hematology and oncology; childhood cancer (e.g., leukemia, lymphoma, brain tumor, neuroblastoma, Wilms' tumor, bone tumor, soft tissue sarcoma); and pediatric hematology (e.g., anemia, thrombocytopenia, neutropenia, bone marrow failure, sickle cell disease, bleeding disorders, ITP). Dr. Ramdas earned his medical degree from Calcutta National Medical College in India. He then moved to the United States to complete his residency and a fellowship in pediatric hematology and oncology at Louisiana State University. Dr. Ramdas is certified by the American Board of Pediatrics in pediatrics and in pediatric hematology-oncology.

Dr. Ramdas is highly rated in 9 conditions, according to our data. His top areas of expertise are Langerhans Cell Histiocytosis, Histiocytosis, Reticulohistiocytoma, Hepatoblastoma, and Bone Marrow Aspiration.

His clinical research consists of co-authoring 7 peer reviewed articles and participating in 40 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution

Calcutta National Medical College, 1988 - Doctor Of Medicine

Residency

Louisiana State University, School of Medicine, 1998

Specialties

Pediatric Hematology Oncology

Licenses

Pediatric Hematology-Oncology in PA

Board Certifications

The American Board Of Pediatrics In Pediatrics And In Pediatric Hematology-Oncology

Fellowships

Louisiana State University, School of Medicine, 2002

Languages Spoken

English
Hindi

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Capital Blue Cross
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Geisinger
  • HMO
  • POS
  • PPO
Health Partners Plans
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
Highmark
  • EPO
  • HMO
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Moda Health
  • EPO
  • PPO
PA Health and Wellness
  • HMO
  • MANAGED MEDICAID PLAN
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
UPMC
  • EPO
  • PPO
View 9 Less Insurance Carriers -

Locations

Geisinger Medical Center - Pediatric Hematology Oncology
100 North Academy Avenue, Danville, PA 17822
Other Locations
Geisinger Wyoming Valley Medical Office Building - Pediatric Hematology Oncology
950 East Mountain Boulevard, Wilkes Barre, PA 18702
Geisinger Pottsville - Pediatric Hematology Oncology
529 Terry Reiley Way, Pottsville, PA 17901
Geisinger Multi-Specialty Clinic Hazleton - Pediatric Hematology Oncology
1525 North Church Street, Hazle Township, PA 18202

Additional Areas of Focus

Dr. Ramdas has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Immune Thrombocytopenic Purpura (ITP)
Neurofibromatosis Type 1 (NF1)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


40 Clinical Trials

NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice) Screening Protocol
A Phase 2 Study of Reduced Therapy for Newly Diagnosed Average-Risk WNT-Driven Medulloblastoma Patients
Pediatric Hepatic Malignancy International Therapeutic Trial (PHITT)
Utilizing Response- and Biology-Based Risk Factors to Guide Therapy in Patients With Non-High-Risk Neuroblastoma
A Phase III Randomized Trial Investigating Bortezomib (NSC# 681239) on a Modified Augmented BFM (ABFM) Backbone in Newly Diagnosed T-Lymphoblastic Leukemia (T-ALL) and T-Lymphoblastic Lymphoma (T-LLy)
Randomized Phase 3 Trial Evaluating the Addition of the IGF-1R Monoclonal Antibody Ganitumab (AMG 479, NSC# 750008) to Multiagent Chemotherapy for Patients With Newly Diagnosed Metastatic Ewing Sarcoma
Risk-Stratified Randomized Phase III Testing of Blinatumomab (NSC#765986) in First Relapse of Childhood B-Lymphoblastic Leukemia (B-ALL)
A Randomized Phase 3 Study of Brentuximab Vedotin (SGN-35) for Newly Diagnosed High-Risk Classical Hodgkin Lymphoma (cHL) in Children and Young Adults
A Phase III Randomized Trial for Newly Diagnosed High Risk B-Lymphoblastic Leukemia (B-ALL) Including a Stratum Evaluating Dasatinib (NSC#732517) in Patients With Ph-like Tyrosine Kinase Inhibitor (TKI) Sensitive Mutations
A Randomized Phase 3 Trial of Nivolumab (NSC# 748726) in Combination With Chemo-Immunotherapy for the Treatment of Newly Diagnosed Primary Mediastinal B-Cell Lymphoma
A Phase 3 Trial Investigating Blinatumomab (NSC# 765986) in Combination With Chemotherapy in Patients With Newly Diagnosed Standard Risk or Down Syndrome B-Lymphoblastic Leukemia (B-ALL) and the Treatment of Patients With Localized B-Lymphoblastic Lymphoma (B-LLy)
Neuroblastoma Biology Studies
Phase III Randomized Trial of Post-Radiation Chemotherapy in Patients With Newly Diagnosed Ependymoma Ages 1 to 21 Years
International Phase 3 Trial in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ALL) Testing Imatinib in Combination With Two Different Cytotoxic Chemotherapy Backbones
A Comprehensive Approach to Improve Medication Adherence in Pediatric ALL
Risk-Stratified Therapy for Acute Myeloid Leukemia in Down Syndrome
Treatment of Patients With Newly Diagnosed Standard Risk B-Lymphoblastic Leukemia (B-ALL) or Localized B-Lineage Lymphoblastic Lymphoma (B-LLy)
Renal Tumors Classification, Biology, and Banking Study
A Groupwide Pilot Study to Test the Tolerability and Biologic Activity of the Addition of Azacitidine (IND# 133688, NSC# 102816) to Chemotherapy in Infants With Acute Lymphoblastic Leukemia (ALL) and KMT2A(MLL) Gene Rearrangement
View 39 Less Clinical Trials
Similar Doctors
Jennifer A. Kovatch
Expertise in
0
conditions
Pediatric Hematology Oncology
Expertise in
0
conditions
Pediatric Hematology Oncology

Geisinger Medical Center - Pediatric Hematology Oncology

100 North Academy Avenue, 
Danville, PA 
 (0.1 miles away)
Languages Spoken:
English, French
Accepting New Patients

Jennifer Ann Kovatch, MD, is a board-certified physician specializing in pediatric hematology oncology.|Dr. Kovatch and her team treat children up to age 13 for conditions such as leukemia/lymphoma, solid tumors, benign tumors and benign hematology (anemia, bleeding disorders and clotting disorders).|Dr. Kovatch performs procedures including lumbar puncture, intrathecal chemotherapy (when chemotherapy is delivered into cerebrospinal fluid), and bone marrow aspiration and biopsy.|She was inspired by her own experience as a pediatric hematology oncology patient to pursue a career in medicine and make a difference in the lives of children. “I love getting to know my patients and helping them achieve their therapeutic goals,” she says.|Dr. Kovatch earned her Doctor of Medicine from the Ross University School of Medicine in the West Indies in 2014. She completed her residency at the University of Missouri in 2017 and a fellowship at the Penn State College of Medicine in 2020.|She is board certified in pediatrics and pediatric hematology oncology by the American Board of Pediatrics.|A New Jersey native, Dr. Kovatch enjoys renovating her home, yardwork and fostering cats in her spare time. Her hobbies include riding her motorcycle and creating artwork. Her top areas of expertise are Acute Lymphoblastic Leukemia (ALL), Immune Thrombocytopenic Purpura (ITP), and Neurofibromatosis Type 1 (NF1).

Girmay H. Tekle
Expertise in
0
conditions
Pediatrics | Pediatric Hematology Oncology
Expertise in
0
conditions
Pediatrics | Pediatric Hematology Oncology

Geisinger Medical Center - Pediatric Hematology Oncology

100 North Academy Avenue, 
Danville, PA 
 (0.1 miles away)
Languages Spoken:
English
Accepting New Patients

Girmay Tekle-Yohannes, MD, is a board-certified pediatric hematologist oncologist. He treats pediatric cancers, including solid tumors and leukemia, and other blood conditions such as anemia, leukopenia, thrombocytopenia, pancytopenia, bleeding disorders and blood clotting disorders. He performs specialized procedures, including bone marrow aspiration, bone marrow biopsy, spinal tap and intrathecal administration of chemotherapy.|Dr. Tekle-Yohannes earned his medical degree from Jimma University in Jimma, Ethiopia. He followed that with residencies at Ethio-Swedish Children’s Hospital/Black Lion Hospital in Addis Ababa, Ethiopia, and Newark Beth Israel Medical Center/Children’s Hospital of New Jersey. After his residencies, he completed a fellowship in pediatric hematology and oncology at Cleveland Clinic Children’s Hospital.|A young child he met during his residency inspired him to practice in his specialty. “That child was exceptionally resilient,” he says. “Their family sold their house to purchase chemotherapy from abroad during a time of drug shortage.”|“The Children’s Oncology Group further consolidated my interest,” he notes. “They developed evidence-based and protocol-based cancer therapy and conducted multi-institution cooperative research that resulted in improvement of childhood cancer survival.”|Dr. Tekle-Yohannes is an accomplished researcher and presenter. He also serves as a clinical assistant professor of pediatrics at Geisinger Commonwealth School of Medicine in Scranton.|He's an active member of several professional organizations and societies, including The American Society of Pediatric Hematology/Oncology, Children’s Oncology Group, American Academy of Pediatrics and American Society of Hematology. His top areas of expertise are Acute Lymphoblastic Leukemia (ALL), Langerhans Cell Histiocytosis, Neurofibromatosis Type 1 (NF1), and Immune Thrombocytopenic Purpura (ITP).

Michal A. Miller
Expertise in
0
conditions
Pediatric Hematology Oncology
Expertise in
0
conditions
Pediatric Hematology Oncology

Geisinger Medical Center - Pediatric Hematology Oncology

100 North Academy Avenue, 
Danville, PA 
 (0.1 miles away)
Languages Spoken:
English
Accepting New Patients

Dr. Miller is a board-certified and fellowship-trained specialist in pediatric hematology/oncology. She attended Eastern Virginia Medical School, where she received her medical degree. She completed her residency at Geisinger Medical Center and her fellowship in pediatric hematology and oncology at the University of Iowa Hospitals and Clinics. Dr. Miller is certified by the American Board of Pediatrics in pediatric hematology-oncology. Her top areas of expertise are Neurofibromatosis Type 1 (NF1) and Immune Thrombocytopenic Purpura (ITP).

Frequently Asked Questions about Dr. Jagadeesh Ramdas

How do I make an appointment with Dr. Jagadeesh Ramdas?

You can book an appointment with Dr. Jagadeesh Ramdas by calling their office at 800-275-6401. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Jagadeesh Ramdas a top-rated expert for Langerhans Cell Histiocytosis?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Jagadeesh Ramdas is classified as an Advanced expert for Langerhans Cell Histiocytosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Jagadeesh Ramdas specialize in?

While Dr. Jagadeesh Ramdas is a Pediatric Hematology Oncology, they have specific expertise in Langerhans Cell Histiocytosis, Histiocytosis, and Reticulohistiocytoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Pediatric Hematology Oncology.

Does Dr. Jagadeesh Ramdas participate in research or clinical trials?

Yes. Dr. Jagadeesh Ramdas has published 7 articles and abstracts on conditions like Langerhans Cell Histiocytosis. You can view a list of Dr. Jagadeesh Ramdas's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Jagadeesh Ramdas accept my insurance?

Dr. Jagadeesh Ramdas accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 800-275-6401 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Ramdas's expertise for a condition
ConditionClose
      View All 9 Advanced Conditions
      View All 10 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile